Literature DB >> 7967617

The evolution of virulence in parasites and pathogens: reconciliation between two competing hypotheses.

R E Lenski1, R M May.   

Abstract

According to conventional wisdom, parasites and pathogens should evolve reduced virulence to their hosts, because more virulent parasites and pathogens are more likely to drive their hosts, and themselves, to extinction. But this view has been criticized for its reliance on group selection. According to an alternative perspective, selection will favor whatever level of virulence maximizes the rate of increase of the parasite or pathogen. This optimum virulence depends on the functional relationship between a parasite or pathogen's transmissibility and its effect on host mortality, with selection often favoring an intermediate degree of virulence. The thesis of this paper is that models in which intermediate levels of virulence are favored lead quite naturally to the further conclusion that parasites and pathogens should-up to a point-become less virulent over time, once the feedbacks between ecological and evolutionary processes are incorporated into the analysis. As a consequence of successive adaptations by the parasite or pathogen, the density of susceptible hosts is reduced, thereby altering the balance between selective forces so as to favor reduced virulence. However, the evolutionarily stable strategy that is achieved is bounded away from complete avirulence. We conclude that models in which intermediate virulence is favored do not necessarily contradict the conventional wisdom in the long run; in fact, these models provide a simple mechanistic explanation for the evolution of reduced virulence.

Mesh:

Year:  1994        PMID: 7967617     DOI: 10.1006/jtbi.1994.1146

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  83 in total

1.  'Small worlds' and the evolution of virulence: infection occurs locally and at a distance.

Authors:  M Boots; A Sasaki
Journal:  Proc Biol Sci       Date:  1999-10-07       Impact factor: 5.349

2.  Transmission bottlenecks as determinants of virulence in rapidly evolving pathogens.

Authors:  C T Bergstrom; P McElhany; L A Real
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

3.  Interactions between sources of mortality and the evolution of parasite virulence.

Authors:  P D Williams; T Day
Journal:  Proc Biol Sci       Date:  2001-11-22       Impact factor: 5.349

4.  Timing of transmission and the evolution of virulence of an insect virus.

Authors:  Vaughn S Cooper; Michael H Reiskind; Jonathan A Miller; Kirsten A Shelton; Bruno A Walther; Joseph S Elkinton; Paul W Ewald
Journal:  Proc Biol Sci       Date:  2002-06-07       Impact factor: 5.349

5.  Selection for plasmid post-segregational killing depends on multiple infection: evidence for the selection of more virulent parasites through parasite-level competition.

Authors:  T F Cooper; J A Heinemann
Journal:  Proc Biol Sci       Date:  2005-02-22       Impact factor: 5.349

6.  Ecological conditions that favor the evolution of intermediate-virulence in an environmentally transmitted parasite.

Authors:  Michael Golinski; Ernest Barany; Mary Ballyk
Journal:  J Math Biol       Date:  2005-06-06       Impact factor: 2.259

7.  Integrating life history and cross-immunity into the evolutionary dynamics of pathogens.

Authors:  Olivier Restif; Bryan T Grenfell
Journal:  Proc Biol Sci       Date:  2006-02-22       Impact factor: 5.349

8.  The evolutionary epidemiology of vaccination.

Authors:  Sylvain Gandon; Troy Day
Journal:  J R Soc Interface       Date:  2007-10-22       Impact factor: 4.118

9.  Transient virulence of emerging pathogens.

Authors:  Benjamin M Bolker; Arjun Nanda; Dharmini Shah
Journal:  J R Soc Interface       Date:  2009-10-28       Impact factor: 4.118

10.  Evolution of acute infections and the invasion-persistence trade-off.

Authors:  Aaron A King; Sourya Shrestha; Eric T Harvill; Ottar N Bjørnstad
Journal:  Am Nat       Date:  2009-04       Impact factor: 3.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.